Atai Life Sciences N.V.
ATAI
$1.47
$0.053.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -112.50% | -85.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -112.50% | -85.35% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -112.50% | -85.35% | |||
| SG&A Expenses | 11.48% | -23.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 29.59% | -12.92% | |||
| Operating Income | -29.84% | 12.15% | |||
| Income Before Tax | -49.91% | 53.81% | |||
| Income Tax Expenses | -303.37% | -1,036.84% | |||
| Earnings from Continuing Operations | -48.19% | 54.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 32.00% | -56.14% | |||
| Net Income | -48.21% | 54.14% | |||
| EBIT | -29.84% | 12.15% | |||
| EBITDA | -29.32% | 12.20% | |||
| EPS Basic | -48.08% | 54.18% | |||
| Normalized Basic EPS | -9.77% | 49.53% | |||
| EPS Diluted | -48.08% | 54.18% | |||
| Normalized Diluted EPS | -9.77% | 49.53% | |||
| Average Basic Shares Outstanding | 0.06% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||